A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Stroke
About this trial
This is an interventional treatment trial for Stroke focused on measuring aneurysm, transient ischemic attack
Eligibility Criteria
Inclusion Criteria (Experimental Group):
- Stroke patients with persistent upper extremity (UE) deficits
Inclusion Criteria (Control Group 1)
- Stroke patients without UE impairments
- Participants with risk factors for stroke
healthy controls
- No known neurologic, psychiatric or developmental disability
Inclusion Criteria (Control Group 2)
- Stroke patients with persistent upper extremity (UE) deficits
- Moderate upper extremity (dominant right hand affected) impairment (score of 1 or 2 on the motor sub-component of the NIH stroke scale (NIHSS) and ARAT score 20-45)
- No upper extremity injury or conditions that limited use prior to the stroke
- Pre-stroke independence with a Modified Rankin Score of 0 or 1, for the standard FES only intervention.
Exclusion Criteria (for all participants):
- Allergic to electrode gel, surgical tape and metals
- Participants under treatment for infectious diseases or having apparent oral lesions or inflammation will be excluded from the study
- Women who are pregnant or may become pregnant during the course of the study will be excluded
- Participants with contraindications for MRI will be offered the opportunity to participate in the interventions study only (e.g. EEG-BCI-FES and behavioral testing)
Exclusion Criteria (for healthy controls)
- Contraindications for MRI
- Allergic to electrode gel, surgical tape, and metals.
Sites / Locations
- University of WisconsinRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Experimental
Experimental
Experimental
Active Comparator
Active Comparator
Experimental Group - Immediate BCI Therapy
Experimental Group - Delayed BCI Therapy
Experimental Group - RecoveriX
Control Group 1
Control Group 2
EEG - BCI training (closed loop)
Scanned and tested 4 times over a 10-week period before EEG-BCI training
Recruited from participants who have completed the study intervention
48 stroke patients, 48 participants with risk factors for stroke, 48 healthy controls receiving 4-6 training sessions on the EEG-BCI, pre- and post- behavioral testing, and MRI
24 Stroke Patients with UE impairment receiving standard FES only therapy